Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration.
The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
This Research brief is summarized from a published clinical study. All the information and statistics cited below were taken directly from the original publication authored by the Age-Related Eye Disease Study 2 (AREDS2) Research Group. Doctor’s Advantage Products, LLC has restructured or paraphrased some sections of this brief in an attempt to more succinctly summarize the research.
Age-related macular degeneration (AMD), the leading cause of blindness in the developed world, accounts for more than 50% of all blindness in the United States. Although intraocular drugs that inhibit vascular endothelial growth factor are currently available for treatment of neovascular AMD, no effective therapies are proven for atrophic AMD.
The Age-Related Eye Disease Study (AREDS) demonstrated that daily oral supplementation with antioxidant vitamins and minerals reduced the risk of developing advanced AMD by 25% at 5 years. Observational studies suggest that higher dietary intake of lutein + zeaxanthin, omega-3 long-chain polyunsaturated fatty acids and eicosapentaenoic acid, or both are associated with a decreased risk of developing advanced AMD. Continue reading Is Age-Related Macular Degeneration Affecting You?